Hypodysfibrinogenemia

Hypodysfibrinogenemia (pronounced: hi-po-dis-fi-brin-o-gen-e-mia) is a rare, inherited disorder that affects the formation and function of fibrinogen, a protein that plays a crucial role in blood clotting.

Etymology

The term "Hypodysfibrinogenemia" is derived from Greek roots: "hypo" meaning under, "dys" meaning bad or difficult, "fibrin" referring to the protein involved in blood clotting, and "gen" meaning produce. The suffix "-emia" is from the Greek "haima" meaning blood. Thus, the term refers to a condition characterized by a deficiency and abnormality in the production of fibrinogen in the blood.

Symptoms

The symptoms of Hypodysfibrinogenemia can vary greatly among affected individuals. Some people may experience no symptoms (asymptomatic), while others may have mild to severe bleeding tendencies, recurrent miscarriages, or abnormal blood clotting (thrombosis).

Diagnosis

Diagnosis of Hypodysfibrinogenemia typically involves blood tests to measure the level and function of fibrinogen. Genetic testing may also be performed to identify mutations in the FGB, FGA, or FGG genes, which are known to cause this disorder.

Treatment

Treatment for Hypodysfibrinogenemia is usually aimed at managing symptoms and preventing complications. This may include medications to control bleeding or prevent clotting, and in severe cases, fibrinogen replacement therapy.

Related Terms

• Fibrinogen
• Thrombosis
• Hemostasis
• Coagulation
• Bleeding disorder

External links

• Medical encyclopedia article on Hypodysfibrinogenemia
• Wikipedia's article - Hypodysfibrinogenemia

This WikiMD dictionary article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski